115 related articles for article (PubMed ID: 1280088)
1. [The culture of mouse bone marrow-derived mast cells (BMMC) and the anaphylactic release of chemical mediators].
Yamamura H; Ohkawa E; Kohno S; Ohata K
Arerugi; 1992 Sep; 41(9):1367-79. PubMed ID: 1280088
[TBL] [Abstract][Full Text] [Related]
2. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
4. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells.
Katz HR; Raizman MB; Gartner CS; Scott HC; Benson AC; Austen KF
J Immunol; 1992 Feb; 148(3):868-71. PubMed ID: 1309842
[TBL] [Abstract][Full Text] [Related]
5. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
[TBL] [Abstract][Full Text] [Related]
6. IL-4 renders mast cells functionally responsive to endothelin-1.
Egger D; Geuenich S; Denzlinger C; Schmitt E; Mailhammer R; Ehrenreich H; Dörmer P; Hültner L
J Immunol; 1995 Feb; 154(4):1830-7. PubMed ID: 7530742
[TBL] [Abstract][Full Text] [Related]
7. Strain difference of murine bone marrow-derived mast cell functions.
Noguchi J; Kuroda E; Yamashita U
J Leukoc Biol; 2005 Sep; 78(3):605-11. PubMed ID: 16126842
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
9. Proliferation and functional responses of bone marrow-derived mast cells after activation.
Levi-Schaffer F; Shalit M
Cell Immunol; 1993 May; 148(2):435-43. PubMed ID: 8495499
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and morphological modifications in dexamethasone-treated mouse bone marrow-derived mast cells.
Pitton C; Michel L; Salem P; Benhamou M; Mencia-Huerta JM; Maclouf J; Prost C; Burtin C; Dubertret L; Benveniste J
J Immunol; 1988 Oct; 141(7):2437-44. PubMed ID: 2459209
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype.
Stevens RL; Bloes WF; Seldin DC; Razin E; Katz HR; Austen KF
J Immunol; 1984 Nov; 133(5):2674-80. PubMed ID: 6332858
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin D2 generation in mouse bone marrow-derived mast cells exposed to dexamethasone is associated with endogenous peroxidase activity.
Michel L; Pitton C; Prost C; Massé JM; Mencia-Huerta JM; Burtin C; Maclouf J; Breton-Gorius J; Benveniste J; Dubertret L
Lab Invest; 1988 Nov; 59(5):613-24. PubMed ID: 2460694
[TBL] [Abstract][Full Text] [Related]
13. The stimuli releasing histamine from murine bone marrow-derived mast cells (BMMC). 3. Effect of coculture with 3T3 fibroblasts on the histamine releasability of BMMC.
Sakaguchi N; Saito H; Iikura Y
Arerugi; 1992 Apr; 41(4):519-25. PubMed ID: 1377904
[TBL] [Abstract][Full Text] [Related]
14. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
[TBL] [Abstract][Full Text] [Related]
15. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
16. Requirement of Smad3 for mast cell growth.
Funaba M; Nakaya K; Ikeda T; Murakami M; Tsuchida K; Sugino H
Cell Immunol; 2006 Mar; 240(1):47-52. PubMed ID: 16839529
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells.
Dayton ET; Caulfield JP; Hein A; Austen KF; Stevens RL
J Immunol; 1989 Jun; 142(12):4307-13. PubMed ID: 2786027
[TBL] [Abstract][Full Text] [Related]
18. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma R-mediated endocytosis and expression of cell surface Fc gamma RIIb1 and Fc gamma RIIb2 by mouse bone marrow culture-derived progenitor mast cells.
Lobell RB; Austen KF; Katz HR
J Immunol; 1994 Jan; 152(2):811-8. PubMed ID: 8283054
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker.
Serafin WE; Dayton ET; Gravallese PM; Austen KF; Stevens RL
J Immunol; 1987 Dec; 139(11):3771-6. PubMed ID: 3680950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
